alexa Treating Alzheimer Disease: Is Diet and Exercise more Effective than Small Molecule Therapy? | OMICS International
ISSN: 2155-9589
Journal of Membrane Science & Technology
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Treating Alzheimer Disease: Is Diet and Exercise more Effective than Small Molecule Therapy?

Kayla C. Castellani1, Elizabeth A. Perry2, George Perry2* and Rudy J. Castellani3

1College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan, USA

2College of Sciences, University of Texas, San Antonio, Texas, USA

3Division of Neuropathology, University of Maryland, Baltimore, Maryland, USA

*Corresponding Author:
George Perry Ph.D
Professor, College of Sciences, University of Texas
San Antonio, Texas, USA
Tel: 210-458-4450
Fax: 210-458-4445
E-mail: [email protected]

Received date December 06, 2012; Accepted date December 08, 2012; Published date December 11, 2012

Citation: Castellani KC, Perry EA, Perry G, Castellani RJ (2013) Treating Alzheimer Disease: Is Diet and Exercise more Effective than Small Molecule Therapy? J Membra Sci Technol 3:e111. doi:10.4172/2155-9589.1000e111

Copyright: © 2013 Castellani KC, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Membrane Science & Technology

As Alzheimer’s disease (AD) therapeutic research continues to pursue small molecule targeting, disease modifying therapy remains elusive [1]. Indeed, despite a wide array of pharmacologic agents at our disposal and the design and completion of dozens of clinical trials targeting Amyloid-beta (Aβ), no approach has shown any progress whatsoever in ameliorating the disease process, and affected patients continue to suffer and expire on the same cognitive trajectory as they have since the dawn of the species. One major defect in the so-called amyloid cascade hypothesis is that the hypothesis itself, as well as essentially all experimental modeling, is derived entirely from Mendelian conditions, i.e. familial autosomal dominant disease [2]. Such conditions are not only exceedingly rare (total number of amyloid β protein precursor mutation kindreds in the world number less than 100, for example), but encompass lifelong defects in cellular physiology. The repeated failures in sporadic AD therapy may simply be due to the inapplicability of this small molecule construct to something as complex as age-related sporadic neurodegeneration. Indeed, an in depth analysis of clinicopathological correlations in sporadic disease reveals that the pathology of AD (and a spectrum of chronic diseases), is indicative of a response to the aging environment, possibly even a productive response, in which case targeting such a response would be ineffective at best, and deleterious at worst. This is to say nothing of the empirical problem with targeting a single small molecule within the scope of the neuronal proteome, comprised of many thousands of protein transcripts at any give time.

It may be time to embrace an aggressively holistic approach to such a disease process that is intimately intertwined with age and the simple passage of time. The many risk factors for sporadic AD, comprised for example of cerebrovascular disease, diabetes mellitus, head trauma and neuroinflammation, neuroendocrinology, and transition metals, suggest that AD is a whole organism disorder that cannot be addressed by any singular construct, least of all lesion targeting. The role of a healthy multi-nutrient diet [3], as both a direct (e.g. antioxidants) and indirect (e.g. reducing obesity and atherosclerosis related risk factors) means of prevention and treatment is already as effective as the most sophisticated of clinical trials to date, and probably more so. Moreover, as the hormesis concept becomes better developed, a judicious exercise program may similarly be of measurable, whole organism benefit, just as hormetic kinetics of Aβ may be operant as a potential factor in the physiology-pathology continuum [4]. Such processes may further underlie the concept of mental “activity,” and the influence of brain usage in the form of educational attainment, as a means of defense against cognitive decline, associated with a given pathological load. At present, it appears that effective therapy for AD associated neurodegeneration is in the distant future and may well take a number of generations, as well as a paradigm shift for measurable progress to occur. Nevertheless, the benefits of something as simple as a healthy diet, mental activity, and a regular exercise program, in combating oxidative stress, neuroinflammation, and the aging process has already proven beneficial to both the quality and quantity of life. Small molecule therapy based on the amyloid cascade model has achieved neither, and unless a different paradigm is pursued, likely never will.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

  • 3rd International Conference on Lipid Science & Technology December 11-12, 2017 Rome, Italy.
    December 11-12, 2017 Rome, Italy
  • 3rd International Conference on Enzymology and Molecular Biology March 05-06, 2018 London, UK.
    March 05-06, 2018 London, UK
  • 3rd International Conference on Biochemistry & Molecular Biology May 16-17, 2018 Singapore.
    May 16-17, 2018 Singapore City, Singapore
  • 11th International Conference and Exhibition on Metabolomics & Systems Biology May 17-19, 2018 Tokyo, Japan.
    May 17-19, 2018 Tokyo, Japan
  • 13th International Conference on Metabolomics and Systems Biology June 11-12, 2018 London, UK.
    June 11-12, 2018 London, UK
  • 8th World Congress on Biopolymers June 28-30, 2018 Berlin, Germany.
    November 19-21-2018 Dubai, Romania
  • 3rd International Conference on Molecular Biology & Nucleic Acids August 27-28, 2018 Toronto, Ontario, Canada.
    August 27-28, 2018 Toronto, Canada
  • 5th International Conference on Glycobiology, Lipids & Proteomics August 27-28, 2018 Toronto, Ontario, Canada.
    August 27-28, 2018 Toronto, Canada
  • International Conference on Computational Biology and Bioinformatics Sep 05-06 2018 Tokyo, Japan.
    Sep 05-06 2018 Tokyo, Japan
  • International Conference on Nutritional Biochemistry September 10-11, 2018 Prague, Czech Republic.
    September 10-11, 2018 Prague, Czech Republic
  • 4th International Conference on Enzymology and Lipid Science September 17-18, 2018 Singapore.
    September 17-18, 2018 Singapore City, Singapore
  • 4th Glycobiology World Congress September 17-19, 2018 Rome, Italy.
    September 17-19, 2018 Rome, Italy
  • 12thInternational Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland.
    November 26-27, 2018 Dublin, Ireland
  • 4th International Conference on Genetic and Protein Engineering December 05-06, 2018 Chicago, USA

Article Usage

  • Total views: 11634
  • [From(publication date):
    June-2013 - Dec 12, 2017]
  • Breakdown by view type
  • HTML page views : 7850
  • PDF downloads : 3784

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

clinica[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version